Vascular smooth muscle cells (SMC) isolated from embryonic and early fetal (e13-e18) rat aortas exhibit an "embryonic growth phenotype" in culture ( Cook, C. L., M. C. M. Weiser, P. E. Schwartz, C. L. Jones, and R. A. Majack. 1994. Circ. . Cells in this growth phenotype exhibit autonomous, serum-independent replication, in contrast to SMC in the "adult" growth phenotype, whose proliferation in culture is dependent on exogenous mitogens. To determine which of these two phenotypes is genetically dominant, heterokaryons were constructed between adult and embryonic (day e17) rat aortic SMC. The fused cells were maintained in serum-free medium for 3 d, then were labeled with bromodeoxyuridine (BrdU) for an additional 24 h. Under these conditions, parental e17 SMC exhibited a high rate of self-driven DNA synthesis (73-85% BrdUpositive cells), while parental adult SMC showed minimal replication (13-21% BrdU-positive cells). Homokaryons of parental cells exhibited parental growth phenotypes and showed the expected mitogenic response when stimulated with serum. Heterokaryons between e17 and adult SMC exhibited a nonautonomous growth phenotype; the "adult" growth phenotype was calculated to be dominant in >89% of all true heterokaryons. The data suggest that adult SMC express molecules capable of genetically extinguishing or otherwise inhibiting the autonomous replication of embryonic SMC. (J. Clin. Invest. 1995. 95:464-468.)
Introduction
Vascular smooth muscle cells (SMC)' occupy a pivotal position in the pathogenesis of a number of vascular disease states including arteriosclerosis, systemic and pulmonary hypertension, and restenosis after angioplasties or vascular reconstructions. Each of these conditions may be characterized, to varying de-grees, by the abnormal replication of vascular SMC. Typically, the proliferation of adult SMC during vascular disease is associated with the reiteration of immature patterns of gene expression (1-6, and Belknap, J. K., N. A. Grieshaber, P. E. Schwartz, M. A. Reidy, and R. A. Majack, manuscript submitted for publication). Despite extensive in vivo and in vitro research, little is actually known about the specific mechanisms which control either the replication or differentiated state of these cells under normal, developmental, or pathological conditions.
In most tissues, cellular differentiation or maturation is associated with dramatic changes in gene expression and replication rates and/or potential. During rat aortic development in vivo, SMC replication has been shown to decrease from an embryonic rate of -80% per day (until day el8) (8) to an adult rate of < 0.06% per day (9, 10) . A major change in replication potential also occurs: early in development (through day e18), aortic SMC exhibit autonomous (serum-independent) replication in culture; this autonomous growth potential appears to be completely lost by day e20 (8) . The factors which drive replication of SMC in the embryonic growth phenotype, and the mechanisms underlying the developmentally timed loss of this phenotype, are unknown.
In this report we describe the growth phenotype of heterokaryons formed between autonomously replicating embryonic SMC and their adult counterparts. Analysis of such heterokaryons, in which nuclear integrity is maintained while cytoplasmic and cell-surface molecules are mixed, allows the identification of trans-acting and diffusible factors responsible for extinguishing or inducing specific traits in the nonexpressing parental cell.. Specifically, in our studies, we sought to determine if adult SMC contain molecules which actively suppress autonomous replication.
Methods
Smooth muscle cells. Embryonic (day e17) aortic SMC were isolated, cultured, and characterized as described by Cook et al. (8) . The isolates of e17 SMC used for these experiments were selected for their high capacity for autonomous replication (the cultures exhibit a 24-h bromodeoxyuridine [BrdU] labeling index, in serum-free medium, of 73-85%) and were used in the 10th through 17th passage. SMC cultured from adult rat aortas were used at similar passages. All cells were cultured in DME supplemented with 10% calf serum (CS). All I1 of DME was then added and the cells were pelleted, resuspended in DME containing 10% CS, and plated on Lab-Tek one-well chamber slides (Nunc, Inc., Naperville, IL). Cells were allowed to attach and spread for 24 h. The cultures were then maintained for 72 h in serumfree DME (SFM), then were labeled with BrdU as described above for an additional 24 h in the absence or presence of 10% CS. For each experiment, parallel control cultures of parental cells were labeled with microspheres, plated onto chamber slides, maintained in SFM for 72 h, then labeled with BrdU for 24 h to determine basal replication rates.
Data analysis. A total of five el7:adult fusion experiments were performed, with qualitatively identical results. A minimum of 120 fusion cells were identified and counted for each individual test condition per experiment. Cells were classified as heterokaryons if they contained two nuclei and if they contained a significant number of both nonfluorescent microspheres (appearing pink under UV fluorescence-dark field illumination) and FITC-labeled microspheres (appearing green under UV fluorescence illumination). Identification of any particular cell as a heterokaryon therefore depended on the simultaneous occurrence of two unambiguously scored independent markers. Heterokaryons were considered to be positively labeled with BrdU if either nucleus of the dikaryon contained peroxidase reaction product. In practice, > 80% of the heterokaryons labeled as "positive" contained two BrdU-labeled nuclei. Rare heterokaryons containing more than two nuclei were not included for analysis. As controls, homokaryons of e17 parents and of adult parents were constructed and analyzed in an identical fashion.
To determine the per cent dominance of the adult (nonautonomous) phenotype, it was necessary to adjust the data for contributions due to heterogeneity within the parental cells (see reference 11 for a more complete discussion). Assuming random fusion of the parental cells, the data were adjusted as follows (11) . The frequencies of all parental phenotypes (BrdU positive or negative after 72 h in SFM) were determined. No differences were observed in labeling indices of parental cell populations cultured individually, after treatment with PEG, or in coculture with the other parental population. Adult SMC replicated at a low but significant level when maintained under serum-free conditions (for the cells used in these experiments, this value was 0.13-0.21); these replicating cells therefore represent a potentially autonomous subpopulation of adult SMC. Similarly, -0.15-0.27 of the e17 parental cells failed to replicate DNA during the 24-h labeling period; they therefore appear as nonautonomous cells and potentially exhibit the adult phenotype. The predicted frequency for each false heterokaryon class possibly contributing to any given phenotype was then determined, and this value was subtracted from the observed fraction of heterokaryons exhibiting the expected behavior for that phenotype. This corrected dominance frequency was then divided by the predicted frequency of heterokaryons derived from parental cells exhibiting the "true" BrdU phenotype (BrdU-negative for adult SMC, BrdU-positive for el7 SMC).
For example, for the data presented in Fig. 3 
Results
The parental cells used in these studies were: (a) highly replicative cultures of embryonic (day e17) rat aortic SMC, exhibiting a 24-h BrdU labeling index of 73-85% after 72 h in SFM (Fig.  1, a and b) matched cultures of adult (3 mo) rat aortic SMC, exhibiting a 24 h BrdU labeling index of 13-21% after 72 h of serum deprivation (Fig. 1 b) . Stimulation of these cells with 10% CS for the final 24 h increased the labeling index to 68%. Adult:adult homokaryons exhibited a labeling index of 15%. Importantly, these cells were fully responsive to the mitogenic effects of 10% CS, which increased the replication rate to 72%. Embryonic SMC (el7) in this experiment exhibited a basal replication rate of 85%; this level of DNA synthesis was maintained in el7:el7 homokaryons. The data therefore demonstrate that PEG-treated, fused SMC are viable, do not lose the ability to replicate DNA in response to normal growth stimuli, and exhibit the expected parental growth phenotypes.
In serum-deprived e17:adult heterokaryons, the labeling index (for the experiment shown) (Fig. 3 ) was found to be 18%, roughly identical to that of adult parental cells and adult:adult heterokaryons. After stimulation with 10% CS, the replication index increased to > 80%, demonstrating the viability of these heterokaryons. The data demonstrate that adult SMC contain or produce molecules capable of repressing the autonomous replication of the e17 nuclei.
The percent dominance of the adult (BrdU-negative after 72 h in SFM) phenotype in homo/heterokaryons was calculated as described in Methods. In adult:adult homokaryons, the adult phenotype was dominant in > 90% of the fused cells. In el7:el7 homokaryons, the per cent dominance of the adult phenotype was 0%. In five separate e17:adult fusion experiments, the adult phenotype was dominant in 94.4, 96.7, 86.7, 80.3, and 88.2% of heterokaryons (see Table I ). The autonomous DNA synthesis observed in e17-derived nuclei therefore was repressed in the context of el7:adult SMC heterokaryons. We conclude that adult SMC contain a nuclear or cytoplasmic factor which is capable of suppressing or blocking the autonomous replication of embryonic SMC.
Discussion
Progressive and sequential changes in gene expression, cellular phenotype, and replication potential drive and regulate most developmental and morphogenetic processes. Appropriate controls over morphogenesis during the development and repair of the vascular system appear to be particularly crucial given the pathological consequences of abnormal blood vessel structure. Examples of vascular pathologies exacerbated or caused by abnormal SMC replication include hypertension (characterized by an increased thickness of the tunica media), vascular malformations (characterized by an underdeveloped tunica media), and arteriosclerosis and restenosis (characterized by the development of a neointima). Little is known concerning the factors which positively or negatively regulate SMC replication during blood vessel development and morphogenesis. The goal of our research is to elucidate the morphogenic mechanisms which determine why SMC stop replicating once blood vessel structure is established; it is our hope that a knowledge of the endogenous growth-suppressive mechanisms operative in the normal blood vessel wall will lead to the eventual development of therapeutic agents effective against vascular disease states involving unregulated SMC proliferation.
A variety of previous studies have utilized heterokaryons to study mechanisms involved in tumor suppression (12, 13) , cellular differentiation (14) (15) (16) (17) (18) (19) , apoptosis (20) , and replication potential (11) . Typically, when cultured cells expressing differentiated functions are fused, the differentiated functions of the parental cells are "extinguished" by factors from the other parental cell type (16, 17) , leading to the concept that differentiated functions must be actively maintained (18, 19) . When cells of the same developmental lineage are fused (e.g., when undifferentiated myoblasts are fused with differentiated muscle cells), the heterokaryons tend to express the more differentiated functions (11, 14) . We have used this technology to study the relative dominance of specific growth phenotypes differentially expressed by embryonic and adult vascular SMC.
During rat aortic development in utero, SMC maturation is associated with the loss of capacity for autonomous replication (8) . Aortic SMC isolated from embryos and fetuses aged el3-e18 exhibit a significant capacity for self-driven replication in culture, and replicate freely under serum-free conditions. The Figure 2 . Identification of e17:adult heterokaryons. Heterokaryons were formed between autonomously replicating, fluorescein-labeled el 7 SMC and their adult counterparts labeled with nonfluorescent microspheres. After fusion, cells were plated and allowed to attach and spread overnight in 10% CS, then were maintained in serum-free DME for a total of 96 h; BrdU was present in the cultures for the final 24 h. Cultures were immunocytochemically stained for BrdU; labeled nuclei appear orange under dark field illumination. Cells containing two nuclei and significant amounts of both cytoplasmic labels were classified as heterokaryons. Note that both nuclei (indicated by arrows) of the e17:adult SMC heterokaryon shown are negative for BrdU staining. Bar, 25 gsm believed to be involved in driving the replication of SMC in the "embryonic growth phenotype" (reference 8 and unpublished data), a similar mechanism, involving the repression of embryospecific gene expression by an adult-specific trans-acting factor, may be operative. Alternatively, the factor responsible for the extinction of the self-driven growth properties of embryonic SMC may act cytoplasmically or on the cell surface. For example, an adult-specific phosphatase, responsible for reversing phosphorylation events involved in driving cellular replication, could maintain normal growth control in adult SMC and consequently in e17:adult heterokaryons. A variety of other models can also be postulated and will be investigated in future studies.
The heterokaryon data also reveal information concerning the molecular mechanisms which drive embryonic SMC growth. These and previous co-culture studies (8) suggest that autonomously replicating el7 SMC do not secrete factors capable of mitogenically stimulating adult SMC. The results of the present study support this concept: if embryonic self-driven replication were due to the overexpression of a mitogen capable of stimulating adult SMC replication, the el7:adult heterokaryons would have been expected to exhibit e17-like growth characteristics.
Regardless of the mechanism of extinction, it is important to recognize that the mechanism responsible for the repression of autonomous replication potential during SMC maturation appears to be actively maintained in the adult. This is apparent given that the inhibitory factor is present in adult SMC (aged 3 mo), long after self-driven growth is initially suppressed during development. Like tumor suppressor genes, expression of this developmentally regulated extinguisher locus may therefore be continuously essential for normal SMC growth control. Loss of molecular basis for this self-driven, embryonic growth phenotype remains unknown. By day 20 of fetal life, the capacity for autonomous replication is completely lost and SMC of older gestational ages exhibit an "adult," serum-dependent growth phenotype in culture (8) . SMC replication during vascular morphogenesis therefore appears to be associated with the successive expression of at least two distinct growth phenotypes. The changes in gene expression which occur across this developmentally timed switch, and the mechanisms controlling these changes, remain under investigation.
The results of the experiments described herein demonstrate that, in embryonic:adult SMC heterokaryons, the adult or nonautonomous growth phenotype is dominant. The results are not due to non-specific growth-inhibitory effects of PEG treatment, since PEG-treated e17 SMC homokaryons maintain the ability to synthesize DNA autonomously in culture, and since adult:adult homokaryons and el7:adult heterokaryons replicate DNA normally in response to serum stimulation. The data therefore indicate that adult SMC acquire, during development, a factor which suppresses or inhibits the autonomous growth potential of embryonic SMC.
The factor may act as a nuclear or trans-acting factor to suppress the transcription of specific genes involved in driving autonomous replication. The wild-type Wilms tumor gene product, for example, is known to suppress transcription of the Atype platelet-derived growth factor and insulin-like growth factor-l genes (21, 22 
